Meet NM320
Early retinal protection without injections
NM320 is the first topical retinal therapy engineered to:
• Reach the posterior retina
• Stabilize retinal bioenergetics
• Reduce oxidative stress
• Help protect retinal cells during early degeneration
Direct access to the posterior retina.
NM320’s lipophilic microemulsion formulation is designed to penetrate ocular barriers and deliver localized exposure behind the eye.
Preclinical studies demonstrate retinal penetration and protective activity following topical delivery.